Jinjing Tan

Beijing, 100069, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes.

SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes.

Journal: Viruses

Published: August 31, 2025

Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non-Small Cell Lung Cancers.

Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non-Small Cell Lung Cancers.

Journal: Cancer medicine

Published: September 22, 2024

Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review.

Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review.

Journal: Translational lung cancer research

Published: July 10, 2024

Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients.

Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients.

Journal: Journal of the National Cancer Center

Published: March 26, 2024

Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.

Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.

Journal: Cancer letters

Published: February 23, 2023

The Relationship between IGF Pathway and Acquired Resistance to Tyrosine Kinase Inhibitors in Cancer Therapy.

The Relationship between IGF Pathway and Acquired Resistance to Tyrosine Kinase Inhibitors in Cancer Therapy.

Journal: Frontiers in bioscience (Landmark edition)

Published: December 14, 2022

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.

Journal: BMC pulmonary medicine

Published: July 26, 2022

VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancer.

VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancer.

Journal: eLife

Published: April 27, 2022

The isocitrate dehydrogenase 1 is a potential prognostic indicator for non-small cell lung cancer patients.

The isocitrate dehydrogenase 1 is a potential prognostic indicator for non-small cell lung cancer patients.

Journal: The International journal of biological markers

Published: November 11, 2021

Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients.

Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients.

Journal: Frontiers in oncology

Published: November 01, 2021

IGFBP7 overexpression promotes acquired resistance to AZD9291 in non-small cell lung cancer.

IGFBP7 overexpression promotes acquired resistance to AZD9291 in non-small cell lung cancer.

Journal: Biochemical and biophysical research communications

Published: June 23, 2021

Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC.

Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC.

Journal: Molecular oncology

Published: May 19, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026